CORRADINI, Elena
 Distribuzione geografica
Continente #
NA - Nord America 10.568
EU - Europa 7.494
AS - Asia 5.555
SA - Sud America 795
Continente sconosciuto - Info sul continente non disponibili 174
AF - Africa 130
OC - Oceania 38
Totale 24.754
Nazione #
US - Stati Uniti d'America 10.347
SE - Svezia 2.240
IT - Italia 1.788
SG - Singapore 1.589
CN - Cina 1.541
GB - Regno Unito 1.296
BR - Brasile 609
DE - Germania 602
VN - Vietnam 595
HK - Hong Kong 543
FI - Finlandia 437
BD - Bangladesh 343
KR - Corea 261
FR - Francia 222
RU - Federazione Russa 194
UA - Ucraina 184
NL - Olanda 135
TR - Turchia 134
IN - India 123
CA - Canada 121
ID - Indonesia 92
AR - Argentina 74
BG - Bulgaria 62
MX - Messico 59
JP - Giappone 55
PL - Polonia 43
LT - Lituania 42
IQ - Iraq 40
IE - Irlanda 36
AU - Australia 34
BE - Belgio 34
PK - Pakistan 33
ZA - Sudafrica 31
AT - Austria 30
ES - Italia 28
AE - Emirati Arabi Uniti 27
RO - Romania 27
MA - Marocco 23
CL - Cile 22
CH - Svizzera 21
EC - Ecuador 21
MY - Malesia 21
UZ - Uzbekistan 19
CO - Colombia 18
VE - Venezuela 18
IL - Israele 16
SA - Arabia Saudita 16
DZ - Algeria 14
EG - Egitto 12
AZ - Azerbaigian 11
PY - Paraguay 11
TN - Tunisia 11
JO - Giordania 10
TW - Taiwan 10
CR - Costa Rica 9
KE - Kenya 9
KZ - Kazakistan 9
PT - Portogallo 9
BO - Bolivia 8
IR - Iran 8
JM - Giamaica 8
NP - Nepal 8
OM - Oman 7
PH - Filippine 7
UY - Uruguay 7
AL - Albania 6
CZ - Repubblica Ceca 6
PE - Perù 6
RS - Serbia 6
BY - Bielorussia 5
DK - Danimarca 5
HU - Ungheria 5
LB - Libano 5
LU - Lussemburgo 5
SI - Slovenia 5
TH - Thailandia 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
GR - Grecia 4
KG - Kirghizistan 4
KH - Cambogia 4
KW - Kuwait 4
SC - Seychelles 4
SY - Repubblica araba siriana 4
AO - Angola 3
HR - Croazia 3
LV - Lettonia 3
MK - Macedonia 3
NG - Nigeria 3
NI - Nicaragua 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CD - Congo 2
CI - Costa d'Avorio 2
CY - Cipro 2
GA - Gabon 2
Totale 24.547
Città #
Stockholm 1.794
Santa Clara 1.049
Ashburn 1.037
Singapore 1.005
Fairfield 869
Southend 821
San Jose 549
Hefei 543
Hong Kong 534
Woodbridge 489
Chandler 485
Houston 415
Helsinki 368
London 318
Seattle 300
Council Bluffs 290
Cambridge 277
Dallas 269
Jacksonville 261
Wilmington 258
Nyköping 255
Beijing 252
Chicago 241
Seoul 231
Los Angeles 229
Modena 219
Ann Arbor 209
Berlin 208
Dearborn 208
Ho Chi Minh City 200
New York 156
Milan 147
Hanoi 146
The Dalles 125
San Diego 102
Bologna 97
Rome 72
Princeton 69
Lauterbourg 65
Munich 61
Sofia 61
Moscow 60
São Paulo 59
Buffalo 58
Frankfurt am Main 58
Shanghai 57
Jakarta 56
Izmir 54
Orem 54
Eugene 50
Parma 48
Salt Lake City 44
Redwood City 43
Phoenix 39
Amsterdam 36
Bremen 36
Atlanta 34
Toronto 34
Tokyo 33
Warsaw 33
Yalova 33
Dublin 28
Brooklyn 27
Brussels 27
Reggio Emilia 27
Elk Grove Village 26
Montreal 26
Nuremberg 26
San Francisco 26
Da Nang 24
Des Moines 24
Florence 24
Redondo Beach 24
Haiphong 23
Kent 23
Chennai 22
Mexico City 22
Bari 21
Boardman 21
Denver 20
Naples 20
Rio de Janeiro 20
Tampa 20
Paris 19
Borzano 18
Turin 18
Hải Dương 17
Turku 17
Baghdad 16
Formigine 16
Hemrik 16
Nanjing 16
Rimini 16
Vienna 16
Brisbane 15
Guangzhou 15
Lappeenranta 15
Columbus 14
Dong Ket 14
North Bergen 14
Totale 16.996
Nome #
Alterations in iron status predict cardiac response to blood transfusion in -thalassemia major 1.837
04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report 499
04092 Liver function, iron status, and hemopoiesis in erythropoietic protoporphyria (EPP): insights into a complex interplay 489
Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene 457
Non-HFE Hepatic Iron Overload. 429
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 429
Regulation of TMPRSS6 by BMP6 and iron in human cells and mice. 419
Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin in Mice. 413
Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy 407
Subacute copper-deficiency myelopathy in a patient with occult celiac disease 405
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a “real life” prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study) 403
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 387
BMP-6 is a Key Endogenous Regulator of Hepcidin Expression and Iron Metabolism 363
Bone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of Hemochromatosis. 361
Iron Regulation of Hepcidin Despite Attenuated Smad1,5,8 Signaling in Mice Without Transferrin Receptor 2 or Hfe. 359
Serum and Liver Iron Differently Regulate the Bone Morphogenetic Protein 6 (BMP6)-SMAD Signaling Pathway in Mice 356
Capitolo 31 "Malattia di Wilson ed emocromatosi", in Sezione V "Malattie del fegato" 356
Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. 351
EASL Clinical Practice Guidelines on haemochromatosis 346
Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes 340
First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy 338
BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice. 337
Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload 335
A PAIR OF BROTHERS WITH ACERULOPLASMINEMIA DUE TO A NOVEL NONSENSE MUTATION: UNUSUAL PHENOTYPE AND EFFECTIVENESS OF IRON-CHELATION THERAPY BY DEFERASIROX 325
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 322
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 315
Altered hepatic BMP signaling pathway in human HFE hemochromatosis 310
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 309
Iron and steatohepatitis. 307
Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad? 301
Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease 294
Disease progression and liver cancer in the ferroportin disease 285
Lack of enterocyte iron accumulation in the ferroportin disease 283
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C 277
A small molecule redistributes iron in ferroportin-deficient mice and patient-derived primary macrophages 272
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) 271
Can Disruption of Basal Ganglia-Thalamocortical Circuit in Wilson Disease Be Associated with Juvenile Myoclonic Epilepsy Phenotype? 267
THE MOLECULAR BASIS FOR THE HEPATIC REGULATION OF HEPCIDIN, THE IRON HORMONE, BY BONE MORPHOGENETIC PROTEINS. 265
GLUCONEOGENIC SIGNALS DIRECTLY CONTROL IRON HOMEOSTASIS THROUGH HEPCIDIN 261
Capitolo 8 "Epatopatie da accumulo: malattia di Wilson ed emocromatosi", in Sezione I "Epatiti acute e croniche" 261
Parametri predittivi e risposta sostenuta alla terapia antivirale combinata nell'epatite cronica attivva HCV correlata (ECA HCV) 260
Fifty meanings of grey 258
Molecular and clinical correlates in iron overload associated with mutations in ferroportin 252
A Pair of Brothers with Aceruloplasminemia Due To A Novel Nonsense Mutation: Unusual Phenotype And Neurological Improvement After Iron-Chelation Therapy With Deferasirox 250
The RGM/DRAGON family of BMP co-receptors. 249
Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease 245
Iron Metabolism in the Disorders of Heme Biosynthesis 239
Clinical application of NGS in the diagnosis of iron overload disorders or hyperferritinemia of genetic origin 232
Hereditary hemochromatosis. 232
CREB-H is a stress-regulator of hepcidin gene expression during early postnatal development 227
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 227
Hereditary Hemochromatosis 225
Genetic iron overload disorders 222
SEX HORMONES DIFFERENTLY REGULATE HEPCIDIN EXPRESSION AND IRON HOMEOSTASIS IN VIVO. 221
Clinical risk scores for the early prediction of severe outcomes in patients hospitalized for COVID-19 214
Haemochromatosis in children: A national retrospective cohort promoted by the A.I.E.O.P. (Associazione Italiana Emato-Oncologia Pediatrica) study group 211
Hyperferritinemia and diagnosis of type 1 Gaucher disease 205
Idiopathic brain calcification in a patient with hereditary hemochromatosis 203
Post COVID-19 irritable bowel syndrome 201
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study 199
Labile plasma iron and echocardiographic parameters are associated to cardiac events in beta-thalassemic patients 197
Fortune favours the bold: finding the right route in the anemia's sea 197
Impact of natural neuromedin-B receptor variants on iron metabolism 197
Hereditary Haemochromatosis: the genes and the disease. 187
null 186
Metodologia per l’adozione di linee guida cliniche in Medicina Interna. 182
STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo 178
Use of digital technologies to support cancer screening in community health promotion interventions: scoping review 178
A Population-based and Clinical Cohort Validation of the Novel Consensus Definition of Metabolic Hyperferritinemia 176
Consensus Statement on the definition and classification of metabolic hyperferritinaemia 174
Assistenza sanitaria primaria. Vol. 2: La formazione medica per il suo sviluppo 173
Iron and the liver 171
Iron in Porphyrias: Friend or Foe? 166
Juvenile hemocromatosis associated with pathogenetic mutations of adult hemocromatosis genes 162
Fegato, pancreas e vie biliari. 157
Author Correction: Consensus Statement on the definition and classification of metabolic hyperferritinaemia (Nature Reviews Endocrinology, (2023), 19, 5, (299-310), 10.1038/s41574-023-00807-6) 154
Haemochromatosis 146
Assistenza sanitaria primaria. Aspetti culturali, metodi e strumenti per il suo sviluppo 144
Corrigendum to “EASL Clinical Practice Guidelines on haemochromatosis” [J Hepatol 2022 (77) 479–502](S0168827822002112)(10.1016/j.jhep.2022.03.033) 140
Prevalence and Characteristics of Metabolic Hyperferritinemia in a Population-Based Central-European Cohort 138
Developing an integrated care pathway to connect home-based palliative care and emergency departments: participatory action research on a quality improvement project 137
Role and challenges to digital technologies in community health promotion programs in Italy during the COVID-19 pandemic: a multiple embedded case study protocol 131
Erratum: Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene (Blood Cells, Molecules, and Diseases (2003) 31 (299-304) DOI: 10.1016/S1079-9796(03)00164-5) 130
Hypoparathyroidism in adults with iron overload diseases (IOD): evidence of a subclinical phenotype 129
Iron overload disorders 128
Haematological parameters in erythropoietic protoporphyria: A multi-national study 118
Reply to: “Ceruloplasmin variants might have different effects in different iron overload disorders” 110
Prevalence of malnutrition and its impact on clinical outcomes in internal medicine wards: The SIMI-NUTRO study 102
Psychological and Clinical Factors Mediate Post‐COVID‐19 Irritable Bowel Syndrome 90
SEX HORMONES DIFFERENTLY REGULATE HEPATIC HEPCIDIN EXPRESSION AND SYSTEMIC IRON HOMEOSTASIS IN VIVO 90
Characterization of ferroportin disease and SLC40A1-related hemochromatosis – Results from the EASL non-HFE registry 87
Genome-wide association for sarcoidosis identifies novel risk loci and genetic heritability in African and European ancestries: a meta-analysis from the Finngen, Million Veteran Program, UK Biobank, and Biobank Japan datasets. 78
Porphyrias: Pathophysiology and clinical management recommendations for hepatologists 61
Lipidic nanomedicines enhance Hinokitiol activity on human primary macrophages from Ferroportin disease patients 47
Totale 24.754
Categoria #
all - tutte 88.956
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.956


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.413 0 127 179 58 82 65 111 104 196 107 216 168
2022/20231.571 153 165 110 137 197 208 44 177 186 39 90 65
2023/20241.179 59 68 128 118 152 83 96 159 35 83 101 97
2024/20254.019 165 48 100 255 757 593 222 223 459 193 501 503
2025/202610.805 560 426 816 817 883 677 1.051 485 2.833 995 594 668
2026/2027582 479 103 0 0 0 0 0 0 0 0 0 0
Totale 24.754